Moleculin Biotech, Inc. Cash
Moleculin Biotech, Inc. (MBRX) had Cash of $7.30 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-13
- 2026-06-30: Cash $7.30M.
- 2026-03-31: Cash $10.30M.
- 2025-12-31: Cash $8.90M.
- 2025-09-30: Cash $6.70M.
| Period end | Cash |
|---|---|
| 2026-06-30 | $7.30M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $10.30M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $8.90M 10-K · filed 2026-03-18 |
| 2025-09-30 | $6.70M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $7.60M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $7.70M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $4.30M 10-K · filed 2025-03-21 |
| 2024-09-30 | $9.40M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $10.80M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $16.80M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $23.60M 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |